API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
39
PharmaCompass offers a list of Methylphenidate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylphenidate manufacturer or Methylphenidate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylphenidate manufacturer or Methylphenidate supplier.
PharmaCompass also assists you with knowing the Methylphenidate API Price utilized in the formulation of products. Methylphenidate API Price is not always fixed or binding as the Methylphenidate Price is obtained through a variety of data sources. The Methylphenidate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methylphenidate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylphenidate, including repackagers and relabelers. The FDA regulates Methylphenidate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylphenidate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methylphenidate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methylphenidate supplier is an individual or a company that provides Methylphenidate active pharmaceutical ingredient (API) or Methylphenidate finished formulations upon request. The Methylphenidate suppliers may include Methylphenidate API manufacturers, exporters, distributors and traders.
click here to find a list of Methylphenidate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Methylphenidate DMF (Drug Master File) is a document detailing the whole manufacturing process of Methylphenidate active pharmaceutical ingredient (API) in detail. Different forms of Methylphenidate DMFs exist exist since differing nations have different regulations, such as Methylphenidate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methylphenidate DMF submitted to regulatory agencies in the US is known as a USDMF. Methylphenidate USDMF includes data on Methylphenidate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methylphenidate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methylphenidate suppliers with USDMF on PharmaCompass.
A Methylphenidate written confirmation (Methylphenidate WC) is an official document issued by a regulatory agency to a Methylphenidate manufacturer, verifying that the manufacturing facility of a Methylphenidate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Methylphenidate APIs or Methylphenidate finished pharmaceutical products to another nation, regulatory agencies frequently require a Methylphenidate WC (written confirmation) as part of the regulatory process.
click here to find a list of Methylphenidate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methylphenidate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methylphenidate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methylphenidate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methylphenidate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methylphenidate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methylphenidate suppliers with NDC on PharmaCompass.
Methylphenidate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylphenidate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylphenidate GMP manufacturer or Methylphenidate GMP API supplier for your needs.
A Methylphenidate CoA (Certificate of Analysis) is a formal document that attests to Methylphenidate's compliance with Methylphenidate specifications and serves as a tool for batch-level quality control.
Methylphenidate CoA mostly includes findings from lab analyses of a specific batch. For each Methylphenidate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylphenidate may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylphenidate EP), Methylphenidate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylphenidate USP).